A 30-year-old Japanese homosexual AIDS patient was admitted to hospital because ofKaposi's sarcoma and mild diarrhea on February 4, 1993. Mud-like stool with blood and mucous was recognized after admission. Although serologic tests for Entamoebahistolytica were negative, trophozoites of E. histolytica were identified in his bloody stool. Daily doses of 1,000 mg of metronidazole were given orally for 6 days and then 750 mg for 4 days, and good results were observed. His CD4 count was 19.5/mm3. Symptomatic amebic colitis was easily treated and good results were obtained even with the extremely diminished CD4count. This is the first published report of symptomatic amebic colitis in an AIDSpatient in Japan. (Internal Medicine 33: 120-122, 1994) 
Introduction
The total number of acquired immunodeficiency syndrome (AIDS) patients in Japan was 601 in August 1993 (1) . AIDSis not a rare disease in Japan. It is well known that intestinal protozoa are much more commonin homosexuals with AIDSrelated conditions than in the general population (2). Among reports on protozoan infection in AIDSpatients in Japan are those on diarrhea due to the infection with Cryptosporidium parvum (3), diarrhea due to Giardia lamblia (4), encephalitis due to Toxoplasma gondii (5) and liver abscess due to Entamoeba histolytica (4). The number of patients with amebiasis due to E. histolytica has recently increased, especially among homosexual men in Japan (6), but to our knowledge, there has been no published report of symptomatic amebic colitis in an AIDS patient in Japan. Wereport a case of symptomatic amebic colitis due to E. histolytica in a Japanese AIDS patient and discuss the diagnosis and therapy. Tables 1 and 2 , respectively. The patient complained of non-bloody diarrhea before admission, but mudlike stool with blood and mucouswas recognized after admission. Microscopic examination of direct stool smear on February 6 revealed trophozoites, which have glasslike pseudopodia and are actively motile, ofE. histolytica, and pathogenic bacteria were not cultured in the stool. Daily doses of 1,000 mgof metronidazole were given orally from February 6 to 12, then 750 mg from February 12 to 16. Bloody stool and diarrhea disappeared on February 8 and 9, respectively (Fig. 1 ). The serum antibody against E. histolytica was negative by gel Amebic Colitis in a AIDS Patient and the zymodemepattern ofE. histolytica isolated from those homosexual men was of non-pathogenic types (7-10) and serum antibody to E. histolytica was not detected in any of the homosexual men with HIV infection (9, 10). Only a few cases of invasive amebiasis in homosexual men have been reported in Western countries (1 1, 12) . However, pathogenic strains of E. histolytica are present among male homosexual communities in Japan, and a distinct epidemiological difference exists between male homosexual communities in Japan and in Western countries (13). In the present case, in spite of the lack ofzymodeme analysis, the protozoa was thought to be the pathogenic type because bloody-mucous stool was found and the stool became normal after administration of an anti-amebic drug. GDPand IHA tests were positive in 85% and 91%, respectively, of cases of amebic colitis with diarrhea and bleeding (14), thus serologic tests have a superior sensitivity and predictive value in the recognition of invasive amebiasis, but the serologic test was negative in the present case. The failure of patients with AIDS to respond after primary immunization with both polysaccharide and protein antigen has been identified: AIDS is associated with an acquired B-cell as well as T-cell immunodeficiency (15). The failure to detect serum antibody with 5 kinds of tests in our patient may be associated with B-cell and T-cell deficiency. The possibilities that humoral immuneresponses do not limit invasive infection with E. histolytica and that humancell-mediated immunity plays a major role in combating invasive infection due to E. histolytica are indicated ( 1 6). Cell-mediated immunity is destroyed in AIDS patients, thus the present patient may have been unable to combat invasive infection by E. histolytica. Our patient, whose CD4count was 19.5/mm3, was relieved with daily doses of 1,000-750 mg ofmetronidazole for 10 days, this study indicates that therapy for symptomatic amebic colitis in an AIDS patient with diminished CD4count may be the same as that in patients with normal immunity. Although the infection rate of E. histolytica is unknownin the Japanese HIVinfected population, 1 3-20% of Japanese homosexual men are positive by ELISA (17). We think that amebic colitis is one of the complications which should be considered in homosexual Japanese AIDSpatients with bloody stool, and treatment by the same methodsused in patients with normal immunitymay achieve good results.
